Weekly paclitaxel as second/third-line treatment in advanced non-small cell lung cancer patients: efficacy and tolerability.
Anticancer Res. 2005 Nov-Dec;25(6C):4611-4.
Anticancer Res. 2005.
PMID: 16334151
Free article.
Clinical Trial.